ENDOGEN ApS: Financial statements 2018
CVR: 29813337
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -25,583 and a net result of DKK -25,908 compared with DKK -7,059 the year before. Equity amounted to DKK 83,421. The solvency ratio was 78.8%. The company had 1 employee in the financial year.
- Gross Profit
- -25,583 kr.
- Profit/Loss
- -25,908 kr.
- Equity
- 83,421 kr.
- Total Assets
- 105,921 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -26 t. | -26 t. | 83 t. | 1 |
| 2017 | 0 | -7 t. | -7 t. | 36 t. | - |
| 2016 | 0 | -13 t. | -14 t. | 43 t. | - |
| 2015 | 19 t. | -16 t. | -16 t. | 56 t. | - |
| 2014 | 19 t. | -36 t. | -37 t. | 70 t. | - |
Keep an eye on ENDOGEN ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of November 23, 2018, Simon Glerup Pedersen has stepped down as adm. dir. of ENDOGEN ApS.
ENDOGEN ApS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK -7,059.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity amounted to DKK -82,428.
